BMV:IBB Holdings Information

BMV:IBB is an equity ETF with a total of 255 individual holdings. The top holdings are Gilead Sciences stock at 7.59%, Vertex Pharmaceuticals at 7.58%, Amgen at 7.38%, Regeneron Pharmaceuticals at 6.15%, and Alnylam Pharmaceuticals at 3.71%.

Total Holdings

255

Top 10 Percentage

45.82%

Asset Class

Equity

ETF Category

Health Care

Assets

132.20B

PE Ratio

21.91

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	GILD	Gilead Sciences, Inc.	7.59%	4,448,117
2	VRTX	Vertex Pharmaceuticals Incorporated	7.58%	1,333,551
3	AMGN	Amgen Inc.	7.38%	1,706,893
4	REGN	Regeneron Pharmaceuticals, Inc.	6.15%	746,515
5	ALNY	Alnylam Pharmaceuticals, Inc.	3.71%	964,440
6	ARGX	argenx SE	3.51%	336,296
7	BIIB	Biogen Inc.	2.68%	1,074,233
8	NTRA	Natera, Inc.	2.48%	965,492
9	RVMD	Revolution Medicines, Inc.	2.43%	1,263,718
10	UTHR	United Therapeutics Corporation	2.30%	310,596
11	INSM	Insmed Incorporated	2.20%	1,563,257
12	ONC	BeOne Medicines AG	2.02%	521,057
13	ILMN	Illumina, Inc.	2.02%	1,090,219
14	INCY	Incyte Corporation	1.81%	1,445,133
15	MRNA	Moderna, Inc.	1.58%	2,650,102
16	NBIX	Neurocrine Biosciences, Inc.	1.45%	716,260
17	ROIV	Roivant Sciences Ltd.	1.32%	3,583,134
18	GMAB	Genmab A/S	1.18%	3,501,569
19	EXEL	Exelixis, Inc.	1.17%	1,842,985
20	IONS	Ionis Pharmaceuticals, Inc.	1.15%	1,186,797
21	BBIO	BridgeBio Pharma, Inc.	1.05%	1,219,502
22	ASND	Ascendis Pharma A/S	1.04%	334,745
23	MDGL	Madrigal Pharmaceuticals, Inc.	1.02%	152,964
24	AXSM	Axsome Therapeutics, Inc.	0.93%	314,090
25	MEDP	Medpace Holdings, Inc.	0.92%	167,292

Showing 25 of 255 holdings

Subscribe to see the full list

Activate Now

As of May 19, 2026